Artículos de revistas
Cognitive Dysfunction and Antiphospholipid Antibodies
Registro en:
Current Rheumatology Reports. Springer, v. 14, n. 1, n. 95, n. 98, 2012.
1523-3774
WOS:000324894300012
10.1007/s11926-011-0224-4
Autor
Appenzeller, S
Lapa, AT
de Carvalho, JF
Peres, FA
Shoenfeld, Y
Institución
Resumen
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Antiphospholipid syndrome (APS) is a multisystem prothrombotic condition, however, in recent years, its inflammatory nature has been studied extensively. Cerebral involvement is commonly observed in APS and results in different clinical manifestations. However, most of the studies include secondary APS. In this article, we review the prevalence, clinical characteristics, and physiopathology of cognitive impairment in patients with primary APS. 14 1 95 98 Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Federico Foundation Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) FAPESP [FAPESP 2008/02917-0, 2009/06049-6] CNPq [300447/2009-4]